2012 annual financial data
BioMarin Pharmaceutical 2012 Operating margin
Direct answer
Operating margin was -22.01%.
Operating income was -110,215,000 USD and net income was -114,347,000 USD.
Operating cash flow was 17,609,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 500,723,000 USD
- Operating income
- -110,215,000 USD
- Net income
- -114,347,000 USD
- Operating cash flow
- 17,609,000 USD